Planning upholds denial of self-storage next to Aldi

A prominent orthopedic surgeon denied during testimony on Wednesday, Dec. 3, in the Tyler Skaggs wrongful death trial that he was informed of the Los Angeles Angels pitcher’s issues with opioids when he performed Tommy John surgery on him in 2014.

The testimony by Dr. Neal ElAttrache contradicted earlier claims by Skaggs’ mother that he was told Skaggs had battled an addiction to painkillers. Since the medical procedure was effectively a workers’ compensation issue for the Angels, the organization would have had access to medical records tied to the Tommy John surgery. Exactly what the team knew about Skaggs’ use of illicit pills and when they knew it is a key question in the ongoing trial.

“Were you ever advised by Tyler Skaggs or anyone in his family that Tyler had a previous issue with opioids?” asked Stephen Ladsous, an attorney for the Angels.

“I can’t recall ever having that discussion,” said ElAttrache, who, along with serving as the head team physician for the Los Angeles Dodgers and Los Angeles Rams, has performed surgery on numerous celebrities and sports figures. “I can’t recall ever linking, in my mind, opioid problems and Tyler.”

ElAttrache confirmed that he prescribed Percocet and oxycodone to help Skaggs deal with his recovery from surgery. The doctor added that had he known of Skaggs’ issues with opioids, he would have instead referred him to a pain management specialist.

“I want to know what is available to me and if the typical ways to relieve pain are not available to me, there are other ways we can do it,” ElAttrache said. “But we can’t go bare after surgery.”

According to testimony and evidence presented during the ongoing trial, Skaggs routinely used illicit opioid pills obtained for him by Eric Kay, a Los Angeles Angels communications staffer. Skaggs also informed several other players that Kay could get pills for them as well.

Tragically, Skaggs died in a Texas hotel room in 2019 at the start of a team road trip. He had snorted a counterfeit pill that Kay provided him, which turned out to contain fentanyl combined with oxycodone and alcohol. Kay is currently serving prison time for his role in Skaggs’ death.

Family members have acknowledged that Skaggs, in 2013, told them about issues he had with Percocet while pitching for the Arizona Diamondbacks. However, the family, as well as Skaggs’ wife and his agent, have denied knowing at the time that his opioid use continued after he was traded to the Angels in 2014.

“I did not think he was using,” said Ryan Hamill, Skaggs’ agent, referring to the pitcher’s time with the Angels. “I never saw any signs.”

During the defense phase of the trial, attorneys for the Angels have continually elicited testimony about Skaggs’ efforts to hide his addiction. They are expected to argue that by hiding his drug use, Skaggs made it impossible for the team to help him and prevent his death.

Attorneys for the team have also pushed back against claims by other former Angels players that the pressure and wear and tear of professional baseball led them to turn to illicit opioids.

In one text exchange from August 2018 shown in court on Wednesday, Skaggs complained that he was hurting after a pitching start but couldn’t get the team to give him a “dose pack,” a prescribed, tapered course of anti-inflammatory steroids. Hamill, his agent, texted Skaggs that teams usually gave those packs out “like candy,” but the agent refused Skaggs’ request for him to secretly obtain a pack, noting it would be illegal.

Hamill, during his testimony, acknowledged that teams have since dialed back their reliance on dose packs since they can be bad for a player’s liver.

“I’d say they were one of the first teams to pull back on handing them out,” he said of the Angels.

Hamill hesitated when asked if he blamed his former client for his illicit drug use.

“I don’t blame Tyler,” he said after a long pause. “I just wish he would have told me.”

Employees who worked in the Angels’ front office, including in the communication and HR departments, have denied knowing that Kay had his own opioid addiction issues or that he was providing pills to Skaggs and other players. But several members of the clubhouse, as well as Kay’s ex-wife, have testified that Kay’s addiction issues were well-known by the team and that they were warned of his drug connections to Skaggs.

The trial is on break Thursday, but testimony will continue Friday in an Orange County Superior Courtroom in Santa Ana.
https://signalscv.com/2025/12/planning-upholds-denial-of-self-storage-next-to-aldi/

Grocery Outlet Holding’s Store Refresh Plan May Succeed

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4848175-grocery-outlet-holding-store-refresh-plan-may-succeed?source=feed_all_articles

Nvidia: The Cycle That Never Ends

Analyst’s Disclosure: I/we have a beneficial long position in the shares of NVDA, META, AMD, NBIS, CRWV either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4847672-nvidia-the-cycle-that-never-ends?source=feed_all_articles

PennantPark Investment: The NAV Continues Its Decline During Q3 (Rating Downgrade)

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4847403-pennantpark-investment-the-nav-continues-its-decline-during-q3-rating-downgrade?source=feed_all_articles

Domino’s Pizza: I Like The Slice Almost As Much As I Like The Stock

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4846915-dominos-pizza-i-like-the-slice-almost-as-much-as-i-like-the-stock?source=feed_all_articles

SCHD: Stop Calling It A Value Fund; It’s A Quality Momentum Strategy

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4846856-schd-stop-calling-it-a-value-fund-its-a-quality-momentum-strategy?source=feed_all_articles

Tesla (TSLA) Stock: The $26 Billion Problem Nobody’s Talking About

TLDR Tesla shares fell 13% in November as retail investors continued buying during the decline A Delaware Supreme Court ruling on Musk’s 2018 pay package could trigger a $26 billion profit hit The potential charge equals more than half of Tesla’s total net income since becoming profitable in 2019 Tesla stock trades at 180 times estimated 2026 earnings compared to 25 times for tech peers Retail investors rotated into Tesla and tech stocks this week before Thursday’s market reversal Tesla shares extended their November slide as retail investors who purchased during the dip now face mounting losses. The stock closed Thursday at $395. 04, marking a 13% decline for the month. Tesla, Inc., TSLA Through Friday, Tesla stock was down approximately 2% year to date. The shares have gained 16% over the trailing 12 months. JPMorgan data shows retail investors actively bought Tesla shares this week. They pulled money from healthcare, industrials, and consumer staples to fund purchases in tech stocks. The buying strategy worked well throughout 2025 until this week. Thursday’s market reversal left many retail investors holding losses on recent purchases. Delaware Court Decision Looms Large Tesla faces a more pressing financial concern than short-term stock movements. The Delaware Supreme Court will soon rule on Musk’s 2018 compensation package. A lower court invalidated the package last year. The judge ruled that negotiations were compromised due to board members’ ties to Musk and their own excessive compensation. If Tesla loses its appeal, the company must account for a replacement stock package at current prices. This creates a $26 billion charge that would hit profits over two years. The amount represents more than half of Tesla’s cumulative net income since 2019. That’s when the company first became profitable. Tesla would need to recognize the expense by August 2027. Spreading $26 billion over eight quarters means $3. 25 billion per quarter in charges. This quarterly expense exceeds Tesla’s actual net income in 21 of the last 25 quarters. The impact would be substantial on reported earnings. Accounting Rules Create Profit Pressure Tesla doesn’t need to pay cash for the stock compensation. The company can simply issue new shares to Musk. However, accounting standards require booking stock compensation as an expense. The logic is that Tesla could have sold those shares on the open market instead. If the Delaware Supreme Court sides with Tesla, Musk keeps his 2018 stock options. The company would avoid additional accounting charges. Those options are currently valued at $116 billion. Brian Dunn from Cornell University said the profit impact signals poor board oversight. He described it as a wealth transfer from shareholders to the company’s largest shareholder. Valuation Gap Widens Tesla stock trades at a premium to tech industry peers. The company’s shares command 180 times estimated 2026 earnings. Amazon, Microsoft, Alphabet, and Meta Platforms trade for an average of 25 times earnings. These companies are building data centers for AI computing. Tesla is developing AI applications including self-driving cars and robots. Revenue from these products hasn’t materialized yet. The company currently faces headwinds from declining car sales. Electric vehicle subsidies are disappearing in key markets. Development costs for projects like humanoid robots continue rising. Tesla disclosed that a failed appeal could materially impact its business and earnings. The board has warned that losing the case might cause Musk to leave the company.
https://blockonomi.com/tesla-tsla-stock-the-26-billion-problem-nobodys-talking-about/

ICSH: Spreads Normalization In Money Markets

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
https://seekingalpha.com/article/4846441-icsh-spreads-normalization-in-money-markets?source=feed_all_articles

Bo Bichette Rejects Blue Jays’ Qualifying Offer — Next Steps

The Toronto Blue Jays got some of the most expected news of the offseason on Tuesday. Bo Bichette officially declined the team’s qualifying offer and is out there for the taking in free agency right now. This was the obvious next step after Toronto tendered him the qualifying offer in the first place. There was never going to be a world in which the 27-year-old star infielder accepted a one-year deal worth just over $22 million. Bichette was one of nine players to officially decline the option. Four players accepted it: Milwaukee Brewers starter Brandon Woodruff, Chicago Cubs starter Shota Imanaga, Detroit Tigers infielder Gleyber Torres and New York Yankees outfielder Trent Grisham. Now that Bichette has declined the qualifying offer, what’s next? Well, it doesn’t change anything about the Blue Jays’ pursuit of him. It has been reported a multitude of times at this point that Toronto wants Bichette back. The fact that he declined the qualifying offer does nothing for the actual pursuit. What it does do is give the Blue Jays cover if he bolts. If Bichette signs elsewhere, the Blue Jays will get draft compensation in return. You can find the entire list of rules provided by MLB right here. Bichette is one of the hottest names on the open market and should cash in with a lucrative, nine-figure deal this offseason. If that isn’t with the Blue Jays, then they will get a draft pick in return, which wouldn’t immediately fill the hole left by the two-time All-Star. All in all, things went as expected on Tuesday. Now, all eyes are on Bichette and he can sign with a team at any time.
https://www.newsweek.com/bo-bichette-rejects-blue-jays-qualifying-offer-next-steps-11070444

Steelers’ Kyle Dugger trade keeps paying off with pick-6 of Joe Flacco

On Sunday afternoon, the Pittsburgh Steelers took the field at home for a crucial divisional matchup against the Cincinnati Bengals. The Bengals had surprisingly defeated the Steelers a few weeks prior, adding extra motivation for Pittsburgh in this rematch.

Coming into the game, the Steelers were still reeling from an ugly road loss against the Los Angeles Chargers the previous week, which dropped their season record to 5-4. However, Sunday’s contest showcased some positive developments, especially on the defensive side.

One of the standout moments came from defensive back Kyle Dugger, who intercepted Bengals quarterback Joe Flacco and returned it for a touchdown. Dugger was traded to the Steelers just three weeks ago in exchange for draft compensation, and his impact on the team has been noticeable. The pick-six occurred at a critical point late in the third quarter, with the Bengals trailing by just four points and threatening in Steelers territory. Dugger’s big play helped shift the momentum firmly in Pittsburgh’s favor.

Overall, the Steelers’ defense has overcome a slow start to the year and has turned into a somewhat formidable unit in recent weeks. This resurgence was evident in a recent comfortable home win against the Indianapolis Colts, where the Steelers forced several key turnovers against a red-hot Colts offense.

Unfortunately, the Steelers’ offense has struggled to keep pace. In particular, Aaron Rodgers had his worst game of the season during the loss to the Chargers, failing to generate much offense.

Looking ahead, the Steelers face a tough road test against the Chicago Bears next Sunday. The game is scheduled to kick off at 1:00 pm ET from Soldier Field in Chicago. Fans will be eager to see if Pittsburgh’s defense can continue its strong play and if the offense can find its rhythm to secure another win on the road.
https://clutchpoints.com/nfl/pittsburgh-steelers/steelers-news-kyle-dugger-trade-keeps-paying-off-pick-6-joe-flacco

.
Privacy Policy Data
Exit mobile version